Fermi Rejects Full Sale as Shares Swing on New Deal

NEW YORK, July 25 —

Fermi Inc. shares surged 18% following a new financing agreement and a Project Matador milestone, even as the board publicly rejected a former CEO's push to sell the company outright. Two separate officer-level personnel changes landed within 10 days of each other, a Regulation FD press release accompanied the financing disclosure, and $7.31 million in insider sales over the past 90 days has moved in one direction only — out.

The Deal and What It Costs

On July 15, Fermi filed an 8-K disclosing three simultaneous material events: a new definitive agreement, the creation of a direct financial obligation, and an unregistered equity sale. Items 1.01, 2.03, and 3.02 filed together typically signal a private placement or a debt-with-equity package — the kind of structure early-stage companies use when conventional capital markets are unavailable or cost-prohibitive.

The market responded with a 18% surge despite 1.9% dilution from the equity component. A Project Matador milestone also contributed, with coverage noting the achievement boosted the company's execution outlook. Milestone progress deserves credit when it represents genuine de-risking. The harder question is what the financing terms actually cost, since the specific economics were not disclosed, and whether a company accepting unregistered equity capital at this stage is gaining strategic runway or managing a shortage of it.

Who Was Selling

While the stock was rising, board members had already been moving in the other direction for weeks. Director James Richard Perry sold 863,637 shares at $7.31 per share on June 30, generating approximately $6.31 million in proceeds. Chief Nuclear Construction Officer Mesut Uzman executed two separate open-market sales on June 3, each approximately $500,000.

Net insider activity over the past 90 days: $7.31 million in open-market sales against zero dollars in purchases. Individual transactions carry many explanations unrelated to a company's near-term prospects. What stands out here is the absence of any offsetting open-market buyer among insiders at any price, over a 90-day window that included both the Project Matador news and the July financing. Perry exited in late June, before the July announcement and the 18% move that followed it. Those who bought the surge paid more than he received.

The Miss Pattern Behind the Price

Three consecutive quarterly results provide context that the current share price does not appear to reflect. Fermi posted EPS of -$0.30 against a consensus estimate of approximately -$0.05 in its most recent quarter. Two quarters prior: -$0.18 against an estimate of roughly -$0.02. Three quarters back: -$0.84 against a consensus of roughly -$0.02.

Development-stage companies lose money. That is not the issue. The issue is the ratio: losses running six to more than thirty times above what analysts projected, for three consecutive periods. That scale of deviation suggests either that the models underlying consensus carry fundamentally wrong assumptions, or that operational performance has materially lagged what prior disclosures implied. Both possibilities are relevant context for any investor building a thesis on a company that is simultaneously raising dilutive capital, rotating leadership, and fending off a sale proposal from a former chief executive.

Governance in Motion

Two 8-K filings in 10 days, on July 13 and July 23, each reporting a director or principal officer departure or appointment, signal that Fermi's leadership structure is actively in transition. That backdrop makes the board's rejection of a former CEO's call for a full company sale more pointed. Contested strategic direction and active leadership turnover are rarely complementary conditions.

Two rounds of additional proxy soliciting materials, filed as DEFA14As on June 15 and June 22, indicate active shareholder solicitation. Companies file DEFA14As when seeking board-level support in contested or sensitive situations. Taken together, the proxy filings, leadership changes, and rejected sale bid from a former executive describe a company working through internal disagreements about its future direction, not one presenting a unified front ahead of a fresh capital raise.

What the Next Quarter Will Tell

The bull case is coherent. Project Matador represents real execution evidence. The July financing extends runway. Nuclear and advanced energy companies carry expected losses through multi-year development timelines, and a single milestone can legitimately reprice probability-weighted outcomes. If the next quarterly report begins closing the gap between actual losses and analyst estimates, and if the governance picture stabilizes, the financing round may prove well-timed.

The more cautious read has more texture. Three consecutive EPS misses of extraordinary magnitude, $7.31 million in one-directional insider sales over 90 days with zero offsetting purchases, two officer-level changes within 10 days, ongoing proxy solicitation, and a rejected full-sale bid cluster in the same direction. None is individually disqualifying. Together they describe a company carrying more internal headwinds than an 18% surge would suggest.

The next quarterly report is the first hard checkpoint. If losses remain far above consensus and insider selling continues without any open-market purchases from directors or officers, the July financing may look less like a growth catalyst and more like capital raised at an elevated price before a difficult disclosure.

Run the free Fermi Inc. deep-dive →

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

What is Fermi Inc.'s stock symbol?

Fermi Inc. trades on NASDAQ under the ticker symbol FRMI. The company is an early-stage energy venture whose Project Matador milestone recently drew significant investor attention and contributed to an 18% share price surge alongside a new financing agreement.

Why did FRMI stock jump 18%?

The surge coincided with a Project Matador milestone that boosted the company's execution outlook and a July 15 8-K disclosing a new material definitive agreement. The same filing also reported 1.9% dilution from an unregistered equity sale, which the market appeared to set aside in response to the milestone news.

Are Fermi Inc. insiders buying or selling stock?

Net insider activity over the past 90 days totals $7.31 million in open-market sales with zero purchases. Director James Richard Perry sold 863,637 shares for approximately $6.31 million on June 30, 2026, and Chief Nuclear Construction Officer Mesut Uzman executed two additional open-market sales totaling approximately $1 million on June 3.

How has Fermi performed on earnings estimates?

Fermi has missed consensus EPS estimates in each of the past three reported quarters by substantial margins, posting -$0.30 against roughly -$0.05, -$0.18 against roughly -$0.02, and -$0.84 against roughly -$0.02 in sequential quarters. The gap between actual losses and consensus expectations has ranged from six to more than thirty times the projected figure.

What is Project Matador for Fermi Inc.?

Project Matador is a Fermi initiative whose recent milestone was cited in news coverage as a driver of the company's share price increase, boosting investor confidence in its execution outlook. Specific technical or financial details of the project's scope were not available in the public filings and news sources reviewed for this article.